Hybridvor 4 Tagen
Director, Senior Corporate Counsel, Germany
Revolution Medicines · München
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors …